Prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression

Prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression

QUESTION 4

Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression?

A. There is too high a risk of serious adverse side effects.

B. It can exaggerate the psychotic symptoms.

C. Clozapine (Clozaril) should not be used as high-dose monotherapy.

D. There is no documentation that clozapine (Clozaril) is effective for patients who are violent.

QUESTION 5

The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP exhibits proper care for this patient?

A. Explaining to the patient that there are no risks of EPS

B. Prescribing the patient 12 mg/dail

C. Titrating the dose by increasing it every 5–7 days

D. Writing a prescription for a higher dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy